Despite surveillance and public awareness, the incidence of melanoma is increasing. Frequently, fine needle aspiration is employed for the diagnosis of metastatic disease, and aspirate material is used for cytogenetic and molecular studies to guide treatment options. The pairing of a weighty diagnosis and the numerous morphologic variants of melanoma can make the cytologic evaluation disquieting. We present some of our experiences and a brief review of the literature to provide helpful diagnostic clues to this malignancy. The clinical history is foremost, although fine needle aspiration of metastatic melanoma is diagnostic prior to identification of the primary lesion in up to a fifth of cases. Given the history of melanoma, pulmonary and subcutaneous nodules that yield no disease should be suspected false negatives. The smearing pattern is usually one of poorly cohesive cells. Frankly malignant, spindled, and epithelioid cell shapes are most common, and cytoplasmic vacuoles, if dutifully sought on Romanowsky stained specimens, can usually be found. The telltale feature of melanin production, while diagnostic, is only present in half of cases. Finally, eccentric placement of the nucleus, nucleoli, and nuclear pseudoinclusions are accessory features. Numerous morphologies of melanoma are possible, but careful consideration of the clinical history, smearing pattern, and nuclear and cytoplasmic features provides guiding diagnostic clues.M elanoma affects more than 800,000 individuals in the United States alone. Furthermore, the reported incidence is increasing despite the decreasing incidences of other common cancers. In the face of improved public awareness, early detection, and aggressive therapy, the morbidity and mortality remain staggering.The understanding of the pathogenesis of melanoma is growing rapidly, which has resulted in significant advancement in diagnosis and treatment of this malignant neoplasm. 1-4 Numerous genomic alterations have been identified in melanomas, and the prevalence of these alterations may differ by the subtype of melanoma as well as by the age of patients. 1 BRAF mutations are of special note because of their relatively higher prevalence in melanoma. Studies showed that at least 40% of melanomas harbor BRAF mutations; among them, the most common mutation is substitution of the valine residue with glutamine at codon 600 (V600E) with a distance second being substitution of the valine with lysine (V600K). 5 Identification of these mutations plays a vital role in the diagnosis, prognosis, and treatment of melanoma. Inhibitors to key enzymes in BRAF pathway are undergoing clinical trials, and the results are promising. 5,6 The diagnosis of primary superficial melanocytic lesions is usually made on tissue obtained by punch biopsy, shave biopsy, or elliptical excision. Fine-needle aspiration (FNA) has very limited role in the diagnosis of the primary lesions except in rare unusual situations. However, the recognition of melanoma is of great importance in the setting of FNAs performed on pa...